Compass Therapeutics Stock (NASDAQ: CMPX) stock price, news, charts, stock research, profile.
You can purchase shares of Compass Therapeutics (NASDAQ:CMPX) through any online brokerage.
Other companies in Compass Therapeutics’s space includes: Molecular Partners (NASDAQ:MOLN), Macrogenics (NASDAQ:MGNX), Inozyme Pharma (NASDAQ:INZY), Kyverna Therapeutics (NASDAQ:KYTX) and TScan Therapeutics (NASDAQ:TCRX).
Compass Therapeutics has a consensus price target of $8.81.
The stock price for Compass Therapeutics (NASDAQ: CMPX) is $1.43 last updated November 22, 2024 at 6:24 PM EST.
There are no upcoming dividends for Compass Therapeutics.
Compass Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Compass Therapeutics.
Compass Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.